If you want specific sources to read, check the New England Journal of Medicine trial on GLP1 agents for metabolic outcomes, the 2024 JAMA Internal Medicine paper on semaglutide and mental health, the 2024 Scientific Reports analysis, and recent reviews by regulatory agencies and psychiatry meetings that discuss case reports and signal detection
Cardiovascular Arrhythmias (including ventricular and supraventricular tachycardia, premature ventricular contractions, and atrial fibrillation), bradycardia, electrocardiographic alterations (including second-degree heart block, QT/QTc interval prolongation, and ST segment depression), palpitations, and syncope
Alternative Therapies: Transitioning to other weight management medications or strategies if GLP-1s are no longer suitable
Do not attempt to drive yourself to hospital
These are usually mild and tend to improve as your body adapts to the medication
Follow the GLP-1 fundamentals: Eat protein first Pause between bites Drink water between meals, not during Keep portions small Q: Is it okay to enjoy desserts
